Health area
Inflammation
Markers such as hs-CRP that rise when the body is inflamed. A single high value can come from a recent infection or injury, so the trend over several tests says more.
The Longevity Panel measures 5 markers in Inflammation. Each one is placed in its range in the app and explained, with the studies behind it.
What we measure
hs-CRP (High-Sensitivity C-Reactive Protein)
mg/LA liver protein that rises within hours of inflammation anywhere in the body, measured here with a high-sensitivity assay that reads the low range relevant to cardiovascular risk. A recent infection, injury or unusually hard exercise session can raise it for a few days, so a single high value may reflect that rather than your usual level.
Neutrophil-to-Lymphocyte Ratio
ratioCalculated from your values
The Neutrophil-to-Lymphocyte Ratio (NLR) is one of the most powerful emerging inflammaging markers. It predicts all-cause mortality, cardiovascular events, and cancer prognosis. Optimal: 1.0–2.5. Above 3.0 indicates elevated inflammation. Above 5.0 is associated with significantly increased mortality risk.
Lymphocyte-to-Monocyte Ratio
ratioCalculated from your values
The Lymphocyte-to-Monocyte Ratio (LMR) reflects immune reserve and immunosenescence. Low LMR predicts worse cancer outcomes and immune dysfunction. Optimal: above 4.0. Below 2.0 signals low immune reserve.
Platelet-to-Lymphocyte Ratio
ratioCalculated from your values
The Platelet-to-Lymphocyte Ratio (PLR) is a systemic inflammatory marker from a standard blood count. Elevated PLR (>150) predicts cardiovascular events, cancer mortality, and sepsis risk.
Systemic Immune-Inflammation Index
indexCalculated from your values
The Systemic Immune-Inflammation Index (SII) combines neutrophils, platelets, and lymphocytes into a single inflammaging score (JAMA Network Open, 2022). Optimal: below 500. High risk: above 1000.
120 markers for every adult, in one visit.
Inflammation is one of 14 health areas in the Longevity Panel, together with three blood clocks, at one price.